1492-11-1 Usage
Description
AC-LEU-OME is a synthetic chemical compound with the amino acid sequence acetyl-leucine-ornithine-methyl ester, often utilized in pharmaceutical and biotechnological research and development. It is a modified peptide that has garnered attention for its potential as a drug delivery system, as well as its antimicrobial, antifungal, and antioxidant properties. AC-LEU-OME's versatility and therapeutic benefits have made it a subject of interest within the scientific community, with ongoing research aimed at exploring its various applications.
Uses
Used in Pharmaceutical Research and Development:
AC-LEU-OME is used as a drug delivery system for enhancing the efficacy and targeting of therapeutic agents. Its unique properties allow for the controlled release and improved bioavailability of drugs, making it a promising candidate for the development of novel pharmaceutical formulations.
Used in Antimicrobial Applications:
AC-LEU-OME is used as an antimicrobial agent for its ability to inhibit the growth of various microorganisms. Its broad-spectrum activity makes it a valuable tool in combating bacterial infections and reducing the risk of antibiotic resistance.
Used in Antifungal Applications:
AC-LEU-OME is used as an antifungal agent for its potential to treat fungal infections. Its ability to target and disrupt fungal cell structures contributes to its effectiveness in controlling and preventing fungal growth.
Used in Antioxidant Applications:
AC-LEU-OME is used as an antioxidant for its potential to neutralize harmful free radicals and protect cells from oxidative damage. This property makes it a candidate for use in various medical applications, including the prevention and treatment of diseases associated with oxidative stress.
Used in Biotechnology:
AC-LEU-OME is used in biotechnological applications for its potential to enhance the production of bioactive compounds and improve the efficiency of biological processes. Its unique properties may contribute to the development of innovative biotechnological solutions in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1492-11-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,9 and 2 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1492-11:
(6*1)+(5*4)+(4*9)+(3*2)+(2*1)+(1*1)=71
71 % 10 = 1
So 1492-11-1 is a valid CAS Registry Number.
1492-11-1Relevant articles and documents
Engineering a polymeric chiral catalyst by using hydrogen bonding and coordination interactions
Shi, Lei,Wang, Xingwang,Sandoval, Christian A.,Li, Mingxing,Qi, Qiaoyan,Li, Zhanting,Ding, Kuiling
, p. 4108 - 4112 (2006)
(Chemical Equation Presented) Noncovalent interactions are used to generate a polymeric supramolecular chiral catalyst (see picture). This heterogeneous catalyst, which is based on Feringa's MonoPhos/RhI system, is formed by orthogonal self-ass
The First Application of a Planar-Chiral Phosphorus Heterocycle in Asymmetric Catalysis: Enantioselective Hydrogenation of Dehydroamino Acids
Qiao, Shuang,Fu, Gregory C.
, p. 4168 - 4169 (1998)
-
Oxidative functionalization of aliphatic and aromatic amino acid derivatives with H2O2 catalyzed by a nonheme imine based iron complex
Ticconi, Barbara,Colcerasa, Arianna,Di Stefano, Stefano,Lanzalunga, Osvaldo,Lapi, Andrea,Mazzonna, Marco,Olivo, Giorgio
, p. 19144 - 19151 (2018/05/31)
The oxidation of a series of N-acetyl amino acid methyl esters with H2O2 catalyzed by a very simple iminopyridine iron(ii) complex 1 easily obtainable in situ by self-assembly of 2-picolylaldehyde, 2-picolylamine, and Fe(OTf)2 was investigated. Oxidation of protected aliphatic amino acids occurs at the α-C-H bond exclusively (N-AcAlaOMe) or in competition with the side-chain functionalization (N-AcValOMe and N-AcLeuOMe). N-AcProOMe is smoothly and cleanly oxidized with high regioselectivity affording exclusively C-5 oxidation products. Remarkably, complex 1 is also able to catalyze the oxidation of the aromatic N-AcPheOMe. A marked preference for the aromatic ring hydroxylation over Cα-H and benzylic C-H oxidation was observed, leading to the clean formation of tyrosine and its phenolic isomers.
IMMUNOSTIMULATING AGENT
-
Paragraph 0181, (2017/05/21)
The present invention aims to provide an immunostimulating agent superior in an immunostimulatory effect, particularly a compound useful as a vaccine adjuvant, a pharmaceutical composition containing the compound, a vaccine containing the compound and an